SEATTLE & MONTREAL--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the launch of its second generation nCounter® Analysis System. The new system features improvements that enable more ambitious translational research studies than have been previously possible, and lays the groundwork for future nCounter-based molecular diagnostics. Improvements in the system include higher throughput, more flexible data analysis software, and hardware designed and manufactured to the quality standards typical of in vitro diagnostics platforms.